KANJINTI
KANJINTI
Approved
DIN Number
02518244
Drug Class
Human
Market Date
Oct 7, 2021
Company
HC
Amgen Canada Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02518244
AIG Number0154252002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
L01FD01 TRASTUZUMAB
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
TRASTUZUMABActive
Strength: 150 MG / VIAL
Monograph: TRASTUZUMAB